High-Avidity Cytotoxic T Lymphocytes Specific for a New Peptide Derived From Preferentially Expressed Antigen of Melanoma (Prame) Can Target Leukemic Precursor Cells.

Proceedings article published in 2011 by C. Quintarelli, B. De Angelis, S. Errichiello, R. Accetta, Palma Md, N. Esposito, Peluso Al, B. Izzo, G. Muccioli Casadei, F. Musella, P. Rinaldi, M. Cosenza, I. Pisano, V. Cacciapuoti, L. Luciano and other authors.

This paper is available in a repository.

Full text: Download

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload